T
Tero Ahola
Researcher at University of Helsinki
Publications - 73
Citations - 6052
Tero Ahola is an academic researcher from University of Helsinki. The author has contributed to research in topics: Semliki Forest virus & Alphavirus. The author has an hindex of 41, co-authored 72 publications receiving 5246 citations. Previous affiliations of Tero Ahola include University of Wisconsin-Madison.
Papers
More filters
Book ChapterDOI
Viral RNA replication in association with cellular membranes.
TL;DR: All plus-strand RNA viruses replicate in association with cytoplasmic membranes of infected cells, and studies of individual nonstructural proteins have revealed that the replication complexes are associated with the membranes and targeted to the respective organelle by the ns proteins rather than RNA.
Journal ArticleDOI
Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase
TL;DR: Mutational analysis in a replicon system showed that the N7-MTase activity was important for SARS virus replication/transcription and can thus be used as an attractive drug target to develop antivirals for control of coronaviruses including the deadly Sars virus.
Journal ArticleDOI
Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP.
Tero Ahola,L Kääriäinen +1 more
TL;DR: It is suggested that in the capping of alphavirus mRNAs the guanine is methylated before linkage to the mRNA molecule.
Journal ArticleDOI
Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.
Yu Chen,Ceyang Su,Min Ke,Xu Jin,Lirong Xu,Zhou Zhang,Andong Wu,Ying Sun,Zhouning Yang,Po Tien,Tero Ahola,Yi Liang,Xinqi Liu,Deyin Guo +13 more
TL;DR: The structure of the nsp16/nsp10 interaction interface shows that nsp10 may stabilize the SAM-binding pocket and extend the substrate RNA-binding groove of nsp15, consistent with the findings in biochemical assays, and suggest that nSp16/Nsp10 interface may represent a better drug target than the viral MTase active site for developing highly specific anti-coronavirus drugs.
Journal ArticleDOI
Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays
TL;DR: The presented approach for discoveringAlphaviral inhibitors enabled us to identify potential lead structures for the development of alphavirus entry and replication phase inhibitors as well as demonstrated the usefulness of CHIKV replicon and SFV as biosafe surrogate models for anti-CHIKV screening.